These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 6308886)

  • 1. Studies of human cytomegalovirus complement-fixing antigen.
    Strulovici D; Copelovici Y; Tanase M; Dumitrescu SM; Cristea A; Teleguta L
    Virologie; 1983; 34(2):119-29. PubMed ID: 6308886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-fixing antigen of human cytomegaloviruses.
    Kim KS; Moon HM; Sapienza VJ; Carp RI
    J Infect Dis; 1977 Feb; 135(2):281-8. PubMed ID: 190330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 6-mercaptopurine on cytomegalovirus replication and complement-fixing antigen formation.
    Horácek J
    Acta Virol; 1978 Mar; 22(2):171. PubMed ID: 26205
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-human cytomegalovirus nuclear antigen antibodies of different immunoglobulin classes.
    Czeglédy J; Gergely L; Váczi L; Vályi-Nagy T
    Acta Virol; 1982 Jan; 26(1-2):73-8. PubMed ID: 6124112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Purification of soluble complement-fixing antigens from two Burkitt's lymphoma cell lines. Conditions affecting the stability and recovery of antigens and antibodies.
    Weliky N; Leaman DH; Kallman BJ
    Immunology; 1975 Oct; 29(4):779-90. PubMed ID: 241721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of cytosine-arabinoside on the multiplication of cytomegalovirus and on the formation of virus-induced intracellular antigens.
    Váczi L; Gönczöl E
    Acta Virol; 1973 May; 17(3):189-95. PubMed ID: 4147136
    [No Abstract]   [Full Text] [Related]  

  • 7. Improved glycine-extracted complement-fixing antigen for human cytomegalovirus.
    Kettering JD; Schmidt NJ; Lennette EH
    J Clin Microbiol; 1977 Dec; 6(6):647-9. PubMed ID: 201666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients.
    Matsunaga T; Sakamaki S; Ishigaki S; Kohda K; Takeda M; Katoh J; Kuroda H; Hirayama Y; Kusakabe T; Akiyama T; Kuga T; Niitsu Y; Masaoka T; Sagawa T; Matsumoto Y
    Int J Hematol; 1999 Feb; 69(2):105-11. PubMed ID: 10071460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of type 2 herpes simplex virus complement-fixing antigen.
    Palmer EL; Martin ML; Warfield DT
    Appl Microbiol; 1971 Nov; 22(5):925-7. PubMed ID: 4332046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus proteins: II. Polypeptide composition of cytomegalovirus complement-fixing antigen.
    Fiala M; Heiner DC; Murnane J; Guze LB
    J Med Virol; 1978; 2(1):39-44. PubMed ID: 210253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of cytomegalovirus antibodies by means of CF, ELISA and immunoblotting techniques.
    Jankowski M; Styczyński P
    Arch Immunol Ther Exp (Warsz); 1987; 35(3):313-9. PubMed ID: 2833198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blastogenic response of human lymphocytes to human cytomegalovirus.
    Waner JL; Budnick JE
    Clin Exp Immunol; 1977 Oct; 30(1):44-9. PubMed ID: 203423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Epstein-Barr virus (EBV) antigens II. Detection of early antigen (S) using anticomplement immunofluorescence (ACIF) et complement fixation (CF) tests.
    Lenoir G; Berthelon MC; Favre MC; De-Thé G
    Biomedicine; 1975 Dec; 23(10):461-4. PubMed ID: 177116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human cytomegalovirus: properties of the complement-fixing antigen.
    Benyesh-Melnick M; Vonka V; Probstmeyer F; Wimberly I
    J Immunol; 1966 Feb; 96(2):261-7. PubMed ID: 4286753
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigenic activity of dense bodies from human cytomegalovirus-infected cells in the complement fixation test.
    Tegtmeier GE
    Yale J Biol Med; 1976 Mar; 49(1):69-70. PubMed ID: 183386
    [No Abstract]   [Full Text] [Related]  

  • 16. A study of complement-fixing, immunofluorescent, and neutralizing antibodies in human cytomegalovirus infections.
    Krech U; Jung M; Sonnabend W
    Z Immunitatsforsch Exp Klin Immunol; 1971 Jun; 141(5):411-29. PubMed ID: 4326069
    [No Abstract]   [Full Text] [Related]  

  • 17. [Obtaining rubella and respiratory syncytial virus complement-fixing antigen of increased activity].
    Chebotarev VV; Moissev VP
    Vopr Virusol; 1971; 16(4):473-5. PubMed ID: 5137549
    [No Abstract]   [Full Text] [Related]  

  • 18. Early nuclear antigen as DNA-binding protein in cytomegalovirus-infected cells.
    Gergely L; Czeglédy J; Váczi L
    Intervirology; 1980; 13(6):352-6. PubMed ID: 6252117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of human cytomegalovirus complement-fixing antigens.
    Dreesman GR; Benyesh-Melnick M
    J Immunol; 1967 Dec; 99(6):1106-14. PubMed ID: 4293994
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibody reactions to virus-specific early antigens (EA) in patients with cytomegalovirus (CMV) infection.
    The TH; Klein G; Langenhuysen MM
    Clin Exp Immunol; 1974 Jan; 16(1):1-7,9-12. PubMed ID: 4143184
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.